tradingkey.logo

STRATA Skin Sciences Inc

SSKN
1.780USD
+0.080+4.71%
Cierre 11/04, 16:00ETCotizaciones retrasadas 15 min
7.42MCap. mercado
PérdidaP/E TTM

STRATA Skin Sciences Inc

1.780
+0.080+4.71%

Más Datos de STRATA Skin Sciences Inc Compañía

STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.

Información de STRATA Skin Sciences Inc

Símbolo de cotizaciónSSKN
Nombre de la empresaStrata Skin Sciences Inc
Fecha de salida a bolsaOct 28, 2005
Director ejecutivoDr. Dolev Rafaeli
Número de empleados106
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 28
Dirección5 Walnut Grove Drive, Suite 140
CiudadHORSHAM
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal19044
Teléfono12156193200
Sitio Webhttps://www.strataskinsciences.com/
Símbolo de cotizaciónSSKN
Fecha de salida a bolsaOct 28, 2005
Director ejecutivoDr. Dolev Rafaeli

Ejecutivos de STRATA Skin Sciences Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
--
--
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
--
-100.00%
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
--
--
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
--
--
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
--
-100.00%
Mr. Shmuel (Samuel) Rubinstein
Mr. Shmuel (Samuel) Rubinstein
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
--
--
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
--
-100.00%
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
--
--
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
--
--
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
--
-100.00%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States (Country)
5.06M
66.03%
China
1.66M
21.65%
Foreign
456.00K
5.95%
Middle East
307.00K
4.01%
Other foreign
181.00K
2.36%
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: sáb., 1 de nov
Actualizado: sáb., 1 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Accelmed Growth Partners Management Ltd
27.37%
22NW, LP
10.19%
Nantahala Capital Management, LLC
7.67%
Lincoln Alternative Strategies LLC
6.94%
Heights Capital Management, Inc.
6.94%
Otro
40.89%
Accionistas
Accionistas
Proporción
Accelmed Growth Partners Management Ltd
27.37%
22NW, LP
10.19%
Nantahala Capital Management, LLC
7.67%
Lincoln Alternative Strategies LLC
6.94%
Heights Capital Management, Inc.
6.94%
Otro
40.89%
Tipos de accionistas
Accionistas
Proporción
Private Equity
27.37%
Investment Advisor/Hedge Fund
10.73%
Hedge Fund
9.81%
Investment Advisor
9.33%
Corporation
6.94%
Individual Investor
0.38%
Otro
35.44%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
39
3.02M
57.24%
+246.62K
2025Q2
42
2.84M
68.01%
+22.22K
2025Q1
49
2.92M
70.24%
+3.78K
2024Q4
50
2.78M
66.72%
+102.20K
2024Q3
53
2.77M
66.42%
+227.70K
2024Q2
54
2.39M
67.77%
-279.08K
2024Q1
55
2.43M
68.82%
-232.89K
2023Q4
54
2.50M
71.18%
-175.24K
2023Q3
53
2.57M
73.29%
-212.86K
2023Q2
52
2.46M
70.54%
-108.10K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Accelmed Growth Partners Management Ltd
1.44M
27.37%
--
--
Sep 04, 2025
22NW, LP
537.00K
10.19%
--
--
Jun 30, 2025
Nantahala Capital Management, LLC
403.92K
7.67%
--
--
Jun 30, 2025
Lincoln Alternative Strategies LLC
365.85K
6.94%
+365.85K
--
Sep 03, 2025
Heights Capital Management, Inc.
365.85K
6.94%
+365.85K
--
Sep 03, 2025
Renaissance Technologies LLC
98.03K
1.86%
-3.80K
-3.73%
Jun 30, 2025
The Vanguard Group, Inc.
84.63K
1.61%
--
--
Jun 30, 2025
Rubinstein (Samuel)
19.86K
0.38%
+18.03K
+983.47%
Mar 31, 2025
Geode Capital Management, L.L.C.
18.19K
0.35%
-76.00
-0.42%
Jun 30, 2025
MGO One Seven LLC
17.14K
0.33%
--
--
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Nombre
Proporción
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Fecha
Tipo
Relación
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
KeyAI